40000 Participants Needed

Radiation Therapy for Cancer

Recruiting at 32 trial locations
TA
MM
MM
KB
Overseen ByKaren Brown
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Proton Collaborative Group
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how different types of radiation therapy affect patients. It examines treatments such as brachytherapy (internal radiation therapy), photon therapy (external beam radiation therapy), proton therapy, and stereotactic radiosurgery (SRS), collecting data from patients scheduled to receive these treatments. The goal is to evaluate the effectiveness of these therapies for various diseases. Candidates are a good fit for this trial if they are scheduled to start radiation therapy and can consent to participate. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important findings.

Do I need to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

A previous study showed that brachytherapy is safe when patients follow their care team's advice. The radiation from brachytherapy seeds decreases quickly, so the risk to others remains low. Research has shown that photon therapy uses strong beams, like X-rays, to target cancer deep inside the body. This type of therapy is well-understood and commonly used.

Proton therapy may cause fewer side effects than traditional radiation because doctors can better control the radiation's path. This precision could make it safer for some patients.

Unfortunately, clear safety data for SRS therapy is not available in the sources. However, extensive studies on other types of radiation therapy suggest they are generally well-tolerated when administered correctly.

Overall, these treatments are widely used, and there is significant experience in managing any side effects. Patients should always discuss concerns with their care team to determine the best approach.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about the diverse radiation therapies being studied because they each offer unique benefits over traditional options like conventional external beam radiation. Brachytherapy delivers radiation directly inside or next to the tumor, which can minimize damage to surrounding healthy tissue. Photon therapy uses X-rays to precisely target tumors, potentially reducing side effects. Proton therapy offers even more precision than photon therapy, as protons stop at the tumor site, sparing nearby healthy tissue. Lastly, Stereotactic Radiosurgery (SRS) provides high-dose radiation in fewer sessions, which can be especially beneficial for treating small, well-defined tumors quickly and effectively. These advanced therapies aim to improve patient outcomes by enhancing precision and reducing treatment time.

What evidence suggests that this trial's radiation therapy treatments could be effective?

This trial includes various types of radiation therapy, each offering distinct benefits. Participants may receive Brachytherapy, which improves survival rates in prostate cancer by increasing tumor sensitivity to radiation. Photon therapy, another option in this trial, has advanced to better target tumors while protecting healthy tissues. Proton therapy, also under study, precisely limits damage to surrounding areas and reduces side effects compared to traditional methods. Stereotactic radiosurgery (SRS) is another treatment option in this trial, providing a survival advantage, especially for brain conditions, with fewer patients needing additional treatments. Each therapy has shown promise in improving outcomes for cancer patients.678910

Who Is on the Research Team?

CV

Carlos Vargas, MD

Principal Investigator

Proton Collaborative Group

Are You a Good Fit for This Trial?

Inclusion Criteria

Planned treatment with radiation therapy
Ability to understand and sign IRB approved consen

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Radiation Therapy

Participants receive various forms of radiation therapy as part of the study

8-12 weeks

Follow-up

Participants are monitored for safety and effectiveness after radiation therapy

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Brachytherapy
  • Photon Therapy
  • Proton Therapy
  • SRS
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Treatment with Radiation TherapyExperimental Treatment1 Intervention

Brachytherapy is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Brachytherapy for:
🇪🇺
Approved in European Union as Brachytherapy for:
🇨🇦
Approved in Canada as Brachytherapy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Proton Collaborative Group

Lead Sponsor

Trials
10
Recruited
41,100+

Citations

Recent progress in radioactive seed implantation ...One study found that brachytherapy can improve tissue radiosensitivity by increasing pO2 in the tumour microenvironment, providing evidence for ...
Meta-analysis of treatment effects for localized prostate ...The effect of BT seed implantation in treating localized prostate cancer is better than that of EBRT. The 5-year overall survival rate of patients is higher.
Brachytherapy (Radioactive Seed Implantation Therapy) in ...Improved urinary morbidity can be attributed to the placement of loose seeds in the apex of the prostate, allowing for more control of radiation ...
The 45-month therapy outcomes of permanent seed ...Brachytherapy has been shown to be relatively minimally invasive, lead to a reduced morbidity and is associated with a minimal length of ...
(125)I Implantation in Lung BrachytherapyIt has been proved, up to 87.2% of 3-year's survival rate that could be achieved by radioactive seeds. Iodine-125 radioactive seeds have a long half life and ...
Radiation Safety for Internal Radiation Therapy ... - OncolinkThe use of brachytherapy is safe, but it is important to follow the safety precautions given to you by your care team after treatment.
Prostate brachytherapyThe low levels of radiation in the seeds generally aren't harmful to others, but as a precaution, you may be asked to avoid close contact with ...
Radiation Safety Assessment in Prostate Cancer TreatmentClinical Patient External Data Validation. In this study, 21 patients were implanted with I-125 radioactive sources. The average total implant ...
Common Questions and AnswersHow long does the radiation last, and am I radioactive after the implant? The radioactivity of the seeds decays very quickly with time. The radiation used for ...
ICRP Publication 98This brachytherapy technique raises a number of radiation safety issues that need specific recommendations from the ICRP.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security